Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA - NYSE:EXK - CA29258Y1034 - Common Stock

8.16 USD
-0.04 (-0.49%)
Last: 11/3/2025, 5:15:24 PM
8.18 USD
+0.02 (+0.25%)
After Hours: 11/3/2025, 5:15:24 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EXK. EXK was compared to 154 industry peers in the Metals & Mining industry. EXK may be in some trouble as it scores bad on both profitability and health. EXK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
In the past year EXK had a positive cash flow from operations.
Of the past 5 years EXK 4 years were profitable.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of EXK (-6.99%) is worse than 64.29% of its industry peers.
EXK's Return On Equity of -13.16% is on the low side compared to the rest of the industry. EXK is outperformed by 64.94% of its industry peers.
EXK has a Return On Invested Capital (0.28%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXK is significantly below the industry average of 12.54%.
Industry RankSector Rank
ROA -6.99%
ROE -13.16%
ROIC 0.28%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

EXK's Operating Margin of 1.11% is in line compared to the rest of the industry. EXK outperforms 51.30% of its industry peers.
EXK's Operating Margin has declined in the last couple of years.
The Gross Margin of EXK (16.47%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of EXK has declined.
Industry RankSector Rank
OM 1.11%
PM (TTM) N/A
GM 16.47%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1

2. Health

2.1 Basic Checks

EXK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, EXK has more shares outstanding
The number of shares outstanding for EXK has been increased compared to 5 years ago.
The debt/assets ratio for EXK is higher compared to a year ago.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.70 indicates that EXK is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of EXK (2.70) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.23 indicates that EXK is not too dependend on debt financing.
EXK has a Debt to Equity ratio (0.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 2.7
ROIC/WACC0.03
WACC8.33%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

EXK has a Current Ratio of 0.93. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.93, EXK is doing worse than 85.71% of the companies in the same industry.
A Quick Ratio of 0.65 indicates that EXK may have some problems paying its short term obligations.
EXK has a worse Quick ratio (0.65) than 82.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.65
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -600.00%.
Looking at the last year, EXK shows a quite strong growth in Revenue. The Revenue has grown by 11.64% in the last year.
The Revenue has been growing by 12.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%46.41%

3.2 Future

The Earnings Per Share is expected to grow by 53.69% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 33.18% on average over the next years. This is a very strong growth
EPS Next Y144.19%
EPS Next 2Y188.31%
EPS Next 3Y96.22%
EPS Next 5Y53.69%
Revenue Next Year87.24%
Revenue Next 2Y75.52%
Revenue Next 3Y48.11%
Revenue Next 5Y33.18%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
EXK is valuated correctly with a Price/Forward Earnings ratio of 16.16.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXK indicates a somewhat cheap valuation: EXK is cheaper than 61.04% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.55. EXK is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 16.16
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

EXK's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 61.35
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXK's earnings are expected to grow with 96.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y188.31%
EPS Next 3Y96.22%

0

5. Dividend

5.1 Amount

EXK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENDEAVOUR SILVER CORP

NYSE:EXK (11/3/2025, 5:15:24 PM)

After market: 8.18 +0.02 (+0.25%)

8.16

-0.04 (-0.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-07 2025-11-07/bmo
Inst Owners50.49%
Inst Owner Change0.6%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap2.37B
Revenue(TTM)247.75M
Net Income(TTM)-69637000
Analysts78.33
Price Target9.75 (19.49%)
Short Float %7.05%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2921.78%
Min EPS beat(2)-5248.51%
Max EPS beat(2)-595.05%
EPS beat(4)1
Avg EPS beat(4)-1901.52%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1033.96%
EPS beat(12)2
Avg EPS beat(12)-718.86%
EPS beat(16)3
Avg EPS beat(16)-586.26%
Revenue beat(2)2
Avg Revenue beat(2)0.08%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.11%
Revenue beat(4)3
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)6.54%
Revenue beat(8)6
Avg Revenue beat(8)-0.8%
Revenue beat(12)8
Avg Revenue beat(12)-0.12%
Revenue beat(16)9
Avg Revenue beat(16)-2.55%
PT rev (1m)40.79%
PT rev (3m)48.1%
EPS NQ rev (1m)47.37%
EPS NQ rev (3m)75%
EPS NY rev (1m)0%
EPS NY rev (3m)-81.77%
Revenue NQ rev (1m)-2.82%
Revenue NQ rev (3m)18.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.16
P/S 9.56
P/FCF N/A
P/OCF 87.4
P/B 4.48
P/tB 4.48
EV/EBITDA 61.35
EPS(TTM)-0.21
EYN/A
EPS(NY)0.51
Fwd EY6.19%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.09
OCFY1.14%
SpS0.85
BVpS1.82
TBVpS1.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.99%
ROE -13.16%
ROCE 0.35%
ROIC 0.28%
ROICexc 0.3%
ROICexgc 0.3%
OM 1.11%
PM (TTM) N/A
GM 16.47%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 3.01
Cap/Depr 503.82%
Cap/Sales 76.86%
Interest Coverage 0.27
Cash Conversion 66.81%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.65
Altman-Z 2.7
F-Score3
WACC8.33%
ROIC/WACC0.03
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y144.19%
EPS Next 2Y188.31%
EPS Next 3Y96.22%
EPS Next 5Y53.69%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%46.41%
Revenue Next Year87.24%
Revenue Next 2Y75.52%
Revenue Next 3Y48.11%
Revenue Next 5Y33.18%
EBIT growth 1Y100.07%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year219.22%
EBIT Next 3Y109.71%
EBIT Next 5Y52.95%
FCF growth 1Y-134.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.85%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status for EXK stock?

ChartMill assigns a valuation rating of 4 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Fairly Valued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for EXK stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to grow by 144.19% in the next year.